Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Brain tumor, child: Astrocytoma/Astrocytic tumors
Stage/Subtype:  childhood cerebral astrocytoma, low-grade
Country:  U.S.A.
Trial Type:  Treatment
Trial Status:  Active
Results 1-14 of 14 for your search:
Start Over
Crizotinib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 21
Sponsor: NCI, Other
Protocol IDs: ADVL0912, COG-ADVL0912, CDR0000647587, NCT00939770
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 12 to 21
Sponsor: NCI
Protocol IDs: NCI-2012-03173, CDR667932, PBTC-029B, PBTC-029, U01CA081457, UM1CA081457, NCT01089101
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 4 to 21
Sponsor: Other
Protocol IDs: 10-096, NCT01294670
Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma
Phase: Phase II
Type: Treatment
Status: Active
Age: 6 months to 17 years
Sponsor: Other
Protocol IDs: CDR0000066504, BC-BT-13, NCT00003468
Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors
Phase: Phase II
Type: Treatment
Status: Active
Age: 6 months to 17 years
Sponsor: Other
Protocol IDs: CDR0000066513, BC-BT-22, NCT00003476
Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation
Phase: Phase II
Type: Natural history/Epidemiology, Treatment
Status: Active
Age: 1 to 25
Sponsor: NCI, Other
Protocol IDs: 10-206, NCT01288235
PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children
Phase: Phase II
Type: Tissue collection/Repository, Treatment
Status: Active
Age: 3 to 21
Sponsor: Other
Protocol IDs: CC#120817, NCT01734512
A Vaccine Trial for Low Grade Gliomas
Phase: Phase II
Type: Treatment
Status: Active
Age: 12 months to less than 22 years
Sponsor: Other
Protocol IDs: PRO1310086, NCT02358187
A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors
Phase: Phase I
Type: Treatment
Status: Active
Age: 3 to 22
Sponsor: Pharmaceutical / Industry
Protocol IDs: 07-098, NCT00634231
Prospective Assessment of Quality of Life (QOL) in Pediatric Patients Treated With Radiation Therapy for Brain Tumors and Non-central Nervous System (Non-CNS) Malignancies
Phase: No phase specified
Type: Natural history/Epidemiology, Treatment
Status: Active
Age: 2 to 25
Sponsor: Other
Protocol IDs: 2005P001629, NCT01115777
A Pilot Study of Glioma Associated Antigen Vaccines in Conjunction With Poly-ICLC in Pediatric Gliomas
Phase: No phase specified
Type: Treatment
Status: Active
Age: 19 months to 20 years
Sponsor: Other
Protocol IDs: PRO08030085, NCT01130077
Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
Phase: No phase specified
Type: Treatment
Status: Active
Age: 70 and under
Sponsor: Other
Protocol IDs: 2011OC057, MT2011-09C, NCT01505569
Start Over